Laura Laemmle-Weidenfeld defends clients against civil and criminal government investigations and litigation relating to allegations of fraud and abuse, particularly under the civil False Claims Act and in the health care and life sciences industries. Ms. Weidenfeld has defended against such investigations brought by the Department of Justice (DOJ), including United States Attorneys Offices throughout the country, as well as the Department of Health and Human Services (HHS) Office of Inspector General, state attorneys general and other state and federal agencies. Also, Ms. Weidenfeld is a member of the firm's Executive Committee.
In addition, Ms. Weidenfeld counsels her clients on compliance-related issues, providing health care fraud and abuse regulatory guidance and helping to establish effective corporate compliance programs. She has represented a broad range of health care providers and manufacturers, including home health care agencies, individual physicians, hospitals, ambulance providers, behavioral health providers and durable medical equipment (DME) providers, as well as major pharmaceutical and medical device manufacturers. Ms. Weidenfeld also represents investors in connection with the due diligence review of health care entities.
Before joining Patton Boggs, Ms. Weidenfeld worked as a trial attorney in the Frauds Section of the DOJ’s Civil Division, where she conducted numerous health care fraud investigations and litigation matters brought under the civil False Claims Act and its qui tam (whistleblower) provisions. During her five years at the DOJ, she worked in conjunction with numerous U.S. Attorneys’ Offices, and her cases focused on alleged violations of the federal Anti-Kickback Statute and Stark Laws, the Federal Food and Drug Cosmetic Act, and various other underlying health care statutes and regulations.
- Successfully represented a national home health care provider in a parallel civil False Claims Act and criminal investigation led by the U.S. Attorneys Office in Newark, NJ, negotiating a global resolution in which the company entered into a Deferred Prosecution Agreement and civil settlements with the United States and more than 30 states, as well as a Corporate Integrity Agreement with the Department of Health and Human Services Office of Inspector General.
- Filed successful motion to dismiss a complaint alleging False Claims Act violations by dialysis provider in connection with the quality of care provided to Medicare and Medicaid patients, in Eastern District of Michigan.
- Filed successful motion to dismiss a complaint alleging False Claims Act violations in connection with marketing practices allegedly undertaken by for-profit provider of higher education, in Middle District of Florida.
- On behalf of individual dermatologist, assisted in successfully negotiating False Claims Act resolution in matter involving alleged violations of the Antikickback Statute.
- Filed successful motions to dismiss government complaint alleging False Claims Act violations by pharmacy chain in connection with Medicaid billings for prescription drugs provided to consumers with primary private insurance coverage, in Western District of Wisconsin.
- Represented an individual consultant who provided FDA-related assistance to a start-up medical device manufacturer, in investigation by the U.S. Attorneys Office in Boston, Massachusetts, under the False Claims Act and Food, Drug and Cosmetic Act, which the U.S. Attorneys Office ultimately declined to pursue.
- On behalf of a well-known nationwide DME provider, successfully resolved False Claims Act litigation relating to marketing practices by negotiating a civil settlement with the Department of Justice and a Corporate Integrity Agreement with the Department of Health and Human Services Office of Inspector General.
- Successfully defended a national home health care provider against a criminal investigation by a state Attorney General’s office, ultimately obtaining a formal declination of the matter, which related to Medicaid billing concerns.